Hasil Pencarian  ::  Simpan CSV :: Kembali

"Latar Belakang: Penanda prognostik dapat menunjang tata laksana stroke iskemik (SI) akut. Protein neuroglobin (Ngb), yang berperan dalam transpor oksigen intrasel neuron dan mengurangi dampak hipoksia, adalah salah satu penanda potensial memenuhi fungsi tersebut.Metode: Studi potong lintang dilakukan pada pasien SI akut yang dirawat di RSUPN dr. Cipto Mangunkusumo pada Maret-April 2023. Sampel serum untuk pemeriksaan Ngb diambil pada tiga hari pasca awitan stroke, sedangkan modified Rankin scale (mRS), National Institutes of Health Stroke Scale (NIHSS), indeks Barthel (BI) dan Montreal Cognitive Assessment (MoCA-Ina) diperiksa pada hari ketujuh. Analisis kemaknaan dan kurva receiver operating characteristic (ROC) digunakan untuk mengetahui hubungan Ngb dengan luaran stroke iskemik akut.Hasil: Sebanyak 42 subjek menjalani analisis. Kadar Ngb serum lebih tinggi pada kelompok dengan skor mRS 3-6 dibandingkan 0-2 (12,42 ng/mL [3,57-50,43] vs 4,79ng/mL [2,25-37,32], p=0,005), dengan skor area di bawah kurva ROC sebesar 0,75. Kadar Ngb juga lebih tinggi pada kelompok dengan NIHSS pulang lebih tinggi (p=0,03), serta BI dan MoCA-Ina yang lebih rendah (p=0,01 dan p=0,002).Kesimpulan: Kadar Ngb serum pada SI akut yang lebih tinggi berkaitan dengan luaran fungsional jangka pendek yang lebih buruk. Penelitian lebih lanjut dibutuhkan sebelum terapan klinis.

---

Background: Prognostic markers can optimize the management of acute ischemic stroke (AIS). The neuroglobin (Ngb), which plays a role in intraneuronal oxygen transport and reduces the effects of hypoxia, is a marker that may perform this function.

Methods: A cross-sectional study was conducted on AIS patients who were treated at RSUPN dr. Cipto Mangunkusumo in March-April 2023. Serum samples for Ngb examination were taken three days after the onset of stroke, while modified Rankin scale (mRS), National Institutes of Health Stroke Scale (NIHSS), Barthel index (BI) and Montreal Cognitive Assessment (MoCA-Ina) were examined on the seventh day. Significance analysis and receiver operating characteristic (ROC) curve were used to determine the relationship between Ngb and AIS outcomes.

Results: A total of 42 subjects underwent analysis. Serum Ngb levels were higher in subjects with mRS score of 3-6 than 0-2 (12.42 ng/mL [3.57-50.43] vs 4.79 ng/mL [2.25-37.32], p=0.005). The area under the ROC curve score was 0.75. Ngb levels were also higher in the group with higher NIHSS at discharge (p=0.03), lower BI (p=0.01) and lower MoCA-Ina score (p=0.002).

Conclusion: Higher serum Ngb levels in AIS are associated with poorer short-term functional outcomes. Further research is needed before clinical application."

"Latar belakang. Gagal jantung akut telah menjadi masalah kesehatan diseluruh dunia. Merokok merupakan salah satu faktor utama dalam insidensi penyakit kardiovaskular dan gagal jantung dan mempengaruhi baik morbiditas maupun mortalitas pada kasus gagal jantung. Saat ini terdapat perbedaan pendapat mengenai pengaruh merokok dengan angka mortalitas akibat gagal jantung.Tujuan. Mengetahui karakteristik pasien gagal jantung akut dan mengidentifikasi hubungan antara riwayat merokok dengan mortalitas pasien gagal jantung akut selama perawatan.Metode. Penelitian dilakukan dengan desain potong lintang dan menggunakan 826 data sekunder dari studi Acute Decompensated Heart Failure Registry (ADHERE) di lima rumah sakit di Indonesia pada bulan Desember 2005 ? 2006.Hasil. Proporsi pasien gagal jantung akut yang mempunyai riwayat merokok di lima rumah sakit di Indonesia pada bulan Desember 2005 ? 2006 mencapai 50,2 %. Angka mortalitas pasien gagal jantung akut adalah 3,6 %. Angka mortalitas pasien gagal jantung akut baik dengan maupun tanpa adalah 3,6 %. Analisis bivariat menunjukkan p=0,978 OR 1,010 CI 0,487-2,094Kesimpulan. Tidak terdapat hubungan bermakna antara riwayat penyakit jantung koroner dengan angka mortalitas gagal jantung akut di lima rumah sakit di Indonesia pada bulan Desember 2005 ? 2006.Background. Acute heart failure has become health problem on the world. Cigarette smoking is a well-established risk factor for cardiovascular disease and heart failure. Nowadays there are controversies between smoking and heart failure mortality Objectives.

Aim. To determine characteristic of patient and relation between history of smoking and mortality of acute heart failure.

Method. This is cross sectional study using 826 data from Acute Decompensated Heart Failure Registry (ADHERE) in five hospital in Indonesia on December 2005 -2006.

Result. 50.2 % patients have history of smoking. Overall in-hospital mortality among patient with acute heart failure is 3.6 %. In-hospital mortality in patient with or without history of smoking is 3.6% with p = 0.978.

Conclusion. There is no significant relation between history of smoking and mortality of acute heart failure in five hospitals in Indonesia on December 2005 -2006."

"ABSTRAKLatar belakang: Keberhasilan operasi TF usia terlambat memiliki kegagalan karena risiko sindrom curah jantung rendah akibat disfungsi ventrikel sebelumnya. Tujuan: mengetahui efek disfungsi ventrikel hasil kateterisasi terhadap luaran jangka pendek sindrom curah jantung rendah dan mortalitas pascakoreksi TF. Metode: penelitian kohort retrospektif data rekam medis. Pasien TF pascakateterisasi diagnostik periode 1 Januari 2015-31 Desember 2016, diikuti dan dievaluasi luaran pascaopersinya berupa mortalitas, sindrom curah jantung rendah dan sindrom respon inflamasi sistemik SRIS . Hasil: terdapat 186 pasien kateterisasi, memiliki 114 data hemodinamik lengkap, 92 menjadi subjek penelitian. Rentang usia 6 bulan-23 tahun 6 bulan, laki-laki lebih banyak daripada perempuan 49 53,3 banding 43 46,7 . Status gizi kurang 64 69,9 , abses serebri 6 6,5 , riwayat spell 64 69,6 , mengalami hemokonsentrasi 56 60,9 , tekanan akhir diastolik ventrikel kanan TDAVKa >12 mmHg 44 47,8 dan ventrikel kiri TDAVKi >12 mmHg 46 50 . Karakteristik pascabedah adalah SRIS 42 45,7 , mortalitas 16 17,4 dan sindrom curah jantung rendah 64 69,6 . Analisis bivariat terhadap mortalitas bermakna untuk saturasi udara ruangan [OR 0,94 IK 0,88-1,003; p=0,037 ], bermakna terhadap sindrom curah jantung rendah adalah peningkatan TDAVKa p=0,017 dan TDAVKi p=0,024 , spell berulang p=0,03 dan SRIS p

---

ABSTRACTBackground successful TF correction at late age has failure because low cardiac output syndrome risk due to known ventricular dysfunction before. Objective to determine the effect of ventricular dysfunction catheterization measurement on short term outcome, comprises of low cardiac output syndrome LCOS and mortality. Methods a retrospective cohort study of medical record. TF child performed diagnostic catheterization from 1 January 2015 31 December 2016, followed and evaluated surgery outcome. Results 186 TF catheterization patients that period, with 114 had complete hemodynamic data, only 92 as research subjects. The age range was 6 months 23 years 6 months, boys were more than girls 58 55.2 vs 46 43.8 . Undernourish was 64 69.9 , 6 6.5 cerebral abscesses, 64 69.6 had spell history, hemoconcentration 56 60.9 , right ventricular end diastolic pressure RVEDP 12 mmHg 44 47.8 and left ventricular end diastolic pressure LVEDP 12 mmHg 46 50 . Outcome for SIRS 42 45.7 , mortality 16 17.4 and LCOS 64 69.6 . Bivariate analysis of predictor variables on mortality was significant for room air saturation, OR 0.94 IK 0.88 1.003, p 0.037 , significant for LCOS was elevated RVEDP variable p 0,017 and LVEDP p 0,024 , recurrent spell p 0,03 and SIRS p"

"Latar Belakang. Takikardia dengan kompleks QRS lebar adalah gambaran EKG yang cukup sering kita temukan. Secara umum ada 3 aritmia yang dapat menyebabkan gambaran takikardia dengan kompleks QRS lebar yaitu: takikardia ventrikel, takikardia supraventrikel dengan aberansi dan takikardia supraventrikel dengan preksitasi. Ketiga aritmia ini penting untuk dibedakan karena memiliki kemaknaan klinis yang sangat berbeda. Berbagai cara sudah diteliti untuk membedakan ke tiga aritmia ini, cara yang sampai saat ini paling sering dipakai adalah dengan menggunakan algoritme ekektrokardiografi. Ada berbagai algoritme yang dapat digunakan, namun sampai sekarang hanya sedikit penelitian yang membandingkan akurasi dari algoritme-algortime tersebut. Penelitian ini akan membandingkan akurasi tiap algoritme-algoritme tersebut dan apabila memungkinkan menyusun suatu algortime baru yang akurat dan mudah digunakan.Metode. Seluruh sampel EKG takikardia dengan kompleks QRS lebar dari bulan Juni 2009 sampai Juni 2013 yang telah menjalani studi elektrofisiologi di Pusat Jantung Nasional Harapan Kita, yaitu sebanyak 62 sampel di analisis oleh 2 orang dengan menggunakan algoritme Brugada, Vereckei, aVR dan R II Wave Peak Time (RIIPWT). Dilakukan analisis tes diagnostik, bivariat dan multivariat untuk tiap-tiap karakteristik EKG dari ke 4 algoritme tersebut. Dari analisa tersebut dibentuklah suatu algoritme baru yang terstruktur dan kemudian dilakukan validasi ulang dengan 56 EKG takikardia dengan kompleks QRS lebar yang berbeda.Hasil. Dalam penelitian ini, hasil tes diagnostik algoritme Brugada memiliki sensitivitas dan spesifisitas yang cukup baik (85.42%; 85.71%), sementara algortime Vereckei memiliki sensitivitas yang paling tinggi (93.73%). Untuk analisis pada tiap-tiap karakteristik EKG didapatkan 4 kriteria EKG memiliki spesifisitas sampai 100%. Pada analisis multivariat didapatkan kriteria EKG adanya gelombang r/q > 40ms pada sadapan aVR dan rasio vi/vt bermakna secara statistik. Kemudian berdasarkan hasil analisis tes diagnostik, multivariat, dan kappa inter dan intra observer dibuatlah algortime baru. Hasil validasi tes diagnostik mendapatkan sensitivitas, akurasi dan Likelihood Ratio algortime baru lebih tinggi dari algoritme-algoritme sebelumnya.Kesimpulan. Karakteristik EKG yang paling bermakna secara statistik untuk membedakan VT dan SVT dengan aberansi pada takikardia dengan kompleks QRS lebar adalah adanya gelombang r/q > 40 ms di sadapan aVR dan rasio vi/vt. Algoritme baru yang dibuat berdasarkan keempat algoritme lainnya memiliki sensitivitas, akurasi, dan likelihood ratio yang lebih tinggi dari keempat algortime lainnya.

---

Background. Wide complex tachycardia is a quite common rhythm that we could find in ECG. Generally there are three arrhytmia that could cause such rhythm in ECG which are: ventricular tachycardia, supraventricular tachycardia with abberancy, supraventricular tachycardia with preexcitation. It is of the utmost importance to be able to differentiate this rhythms for they hold a very different clinical value. Many methods was used to differ this three arrhytmia, among all of them the electrocardiography algorthytm was one of the most commonly used. This study will compared all the accuracy of the previous algorhythms and if possible to developed a new accurate and simple algorhythm based on the previous algorhythm.

Method. All wide QRS complex tachycardia electrocardiography spanning from June 2009 up until June 2013 whose diagnosis confirmed by electrophysiology study at National Heart Center Harapan Kita with the sum of 62 samples were analyzed by 2 researcher using the Brugada, Vereckei, aVR, and R II Peak Wave Time. Diagnosis test was then performed with bivariat and multivariat analysis for every ECG criteria from the four previous algorhythm. From the previous analysis a new and structured algorhythm was formed and validity test was performed afterward using a different set of 56 wide QRS complex tachycardia.

Result. From the diagnostic analysis, the Brugada algorhythm come out with a formidable sensitivity dan specificity (85.42%; 85.71%), while the Vereckei algorhythm has the highest sensitivity (93.73%). There are four ECG criteria with 100% specificity. The multivariat analysis reveal two statistically significant ECG criteria which are the existence of r or q wave > 40 ms in the aVR lead and the vi/vt ratio. Based on the multivariat analysis, and kappa inter and intra observer, new algorhythm was formed. The Validity test afterward reveal the sensitivity, accuracy and likelihood ratio of the new algorhythm were superior compared with the previous algorhythm.

Conclusion. The most statitiscally significant ECG characteristic for differentiating VT and SVT with abberancy in wide QRS complex tachycardia were are the existence of r or q wave > 40 ms in the aVR lead and the vi/vt ratio. The new algorhythm build based on the four previous algorhythm has superior sensitivity, accuracy, and likelihood ratio compared with the previous algorhythms."

"ABSTRAK Latar belakang: disglikemia adalah keadaan intoleransi glukosa berupa peningkatan kadar gula darah yang berhubungan dengan risiko penyakit kardiovaskular. Seiring dengan waktu, pada akhirnya diabetes akan menimbulkan kerusakan pada target organ, salah satu yang penting adalah pada sistem organ kardiovaskular, dapat berupa penyakit jantung koroner, kardiomiopati diabetes, penyakit serebrovaskuler, dan penyakit arteri perifer. Diabetes juga meningkatkan risiko terjadinya gagal jantung. Pada kardiomiopati diabetes, proses fibrosis yang masih reversibel sudah mulai terjadi bahkan ketika penderita masih asimtomatik. Pemeriksaan baku emas untuk mendeteksi terjadinya fibrosis miokard secara dini adalah pemeriksaan histopatologi jaringan miokardium melalui biopsi. Akan tetapi pemeriksaan ini sangat invasif dan tidak nyaman bagi subjek. Pemeriksaan yang kemudian berkembang adalah pencitraan menggunakan Cardiac Magnetic Resonance Imaging (CMRI). Akan tetapi pemeriksaan ini cukup mahal, dan tidak tersedia pada semua fasilitas kesehatan. Sementara itu, ST2 adalah penanda enzim jantung yang menggambarkan derajat proses fibrosis yang sedang terjadi pada miokard, terutama pada keadaan gagal jantung. Pemeriksaan menggunakan penanda enzim dapat menjadi alternatif dengan keuntungan lebih murah, dapat terjangkau luas dan mudah tersedia. Tujuan: Mengetahui hubungan antara kadar ST2 serum dengan fibrosis miokard interstisial pada penderita disglikemia. Metode: Pasien disglikemia yang lolos kriteria eksklusi berupa komorbid kardiovaskular akan menjalani pemeriksaan kadar ST2 serum dan T1 relaxation time menggunakan Cardiac MRI. Selanjutnya dilakukan analisis hubungan antara kadar ST2 serum dan T1 relaxation time. Hasil penelitian: Sebanyak 34 pasien diikutsertakan ke dalam penelitian ini. Didapatkan kisaran nilai kadar ST2 serum antara 12.40-53.22 ng/dL (median 19.95 ng/dL). Rerata nilai T1 relaxation time didapatkan sebesar 443.39 ± 113.35 ms. Terdapat korelasi bermakna antara kadar ST2 serum dengan fibrosis diffuse miokardium (Spearman correlation r = -0,547, p < 0.01). Pada analisa multivariat hubungan antara kadar ST2 serum dan T1 relaxation time tidak dipengaruhi oleh faktor perancu yang telah ditetapkan (r = -0,44, p = 0,033). Kesimpulan: Hasil penelitian ini menunjukkan kadar ST2 serum berkolerasi dengan fibrosis diffuse miokardium pada populasi disglikemia.ABSTRACT Background: disglycemia is a state of glucose intolerance include increased blood sugar levels associated with risk of cardiovascular disease. Over time, eventually diabetes will cause damage to the target organ, especially the cardiovascular system, which include coronary heart disease, diabetic cardiomyopathy, diabetes, cerebrovascular disease, and peripheral arterial disease. Diabetes also increases the risk of heart failure. The clinical appearance of the disease is wide ranging from asymptomatic to symptomatic heart failure. Gold standard examination to detect the occurrence of early myocardial fibrosis is histopathological examination of myocardial tissue via biopsy. However, these tests are very invasive and uncomfortable for the subject. Examination which later evolved is imaging using cardiac magnetic resonance imaging (CMRI). However, these tests are quite expensive, and not available at all health facilities. Meanwhile, ST2 is a cardiac enzyme marker that describes the degree of fibrosis process in the myocardium, especially in the state of heart failure. Examination using enzyme markers can be a cheaper alternative, widely accessible and readily available. Aim: Knowing the relationship between serum levels of ST2 with myocardial interstitial fibrosis in disglycemic patients. Methods: Disglycemic patients who passed from the exclusion criteria (cardiovascular comorbid), will undergo a serum ST2 levels and T1 relaxation time using cardiac MRI. Then we analyzed the relationship between serum levels of ST2 and T1 relaxation time. Results: A total of 34 patients were included in this study. The range values of serum ST2 levels were between 12.40-53.22 ng/dL (median 19.95 ng/dL). The mean value of T1 relaxation time were 443.39 ± 113.35 ms. There is a significant correlation between serum levels of ST2 with diffuse myocardial fibrosis (Spearman correlation r = -0.547, p <0:01). Multivariate analysis showed the relationship between serum levels of ST2 and T1 relaxation time is not influenced by confounding factors (r = -0.44, p = 0.033). Conclusion: ST2 serum levels correlates with diffuse myocardial fibrosis on disglycemic population.;Background: disglycemia is a state of glucose intolerance include increased blood sugar levels associated with risk of cardiovascular disease. Over time, eventually diabetes will cause damage to the target organ, especially the cardiovascular system, which include coronary heart disease, diabetic cardiomyopathy, diabetes, cerebrovascular disease, and peripheral arterial disease. Diabetes also increases the risk of heart failure. The clinical appearance of the disease is wide ranging from asymptomatic to symptomatic heart failure. Gold standard examination to detect the occurrence of early myocardial fibrosis is histopathological examination of myocardial tissue via biopsy. However, these tests are very invasive and uncomfortable for the subject. Examination which later evolved is imaging using cardiac magnetic resonance imaging (CMRI). However, these tests are quite expensive, and not available at all health facilities. Meanwhile, ST2 is a cardiac enzyme marker that describes the degree of fibrosis process in the myocardium, especially in the state of heart failure. Examination using enzyme markers can be a cheaper alternative, widely accessible and readily available. Aim: Knowing the relationship between serum levels of ST2 with myocardial interstitial fibrosis in disglycemic patients. Methods: Disglycemic patients who passed from the exclusion criteria (cardiovascular comorbid), will undergo a serum ST2 levels and T1 relaxation time using cardiac MRI. Then we analyzed the relationship between serum levels of ST2 and T1 relaxation time. Results: A total of 34 patients were included in this study. The range values of serum ST2 levels were between 12.40-53.22 ng/dL (median 19.95 ng/dL). The mean value of T1 relaxation time were 443.39 ± 113.35 ms. There is a significant correlation between serum levels of ST2 with diffuse myocardial fibrosis (Spearman correlation r = -0.547, p <0:01). Multivariate analysis showed the relationship between serum levels of ST2 and T1 relaxation time is not influenced by confounding factors (r = -0.44, p = 0.033). Conclusion: ST2 serum levels correlates with diffuse myocardial fibrosis on disglycemic population.;Background: disglycemia is a state of glucose intolerance include increased blood sugar levels associated with risk of cardiovascular disease. Over time, eventually diabetes will cause damage to the target organ, especially the cardiovascular system, which include coronary heart disease, diabetic cardiomyopathy, diabetes, cerebrovascular disease, and peripheral arterial disease. Diabetes also increases the risk of heart failure. The clinical appearance of the disease is wide ranging from asymptomatic to symptomatic heart failure. Gold standard examination to detect the occurrence of early myocardial fibrosis is histopathological examination of myocardial tissue via biopsy. However, these tests are very invasive and uncomfortable for the subject. Examination which later evolved is imaging using cardiac magnetic resonance imaging (CMRI). However, these tests are quite expensive, and not available at all health facilities. Meanwhile, ST2 is a cardiac enzyme marker that describes the degree of fibrosis process in the myocardium, especially in the state of heart failure. Examination using enzyme markers can be a cheaper alternative, widely accessible and readily available. Aim: Knowing the relationship between serum levels of ST2 with myocardial interstitial fibrosis in disglycemic patients. Methods: Disglycemic patients who passed from the exclusion criteria (cardiovascular comorbid), will undergo a serum ST2 levels and T1 relaxation time using cardiac MRI. Then we analyzed the relationship between serum levels of ST2 and T1 relaxation time. Results: A total of 34 patients were included in this study. The range values of serum ST2 levels were between 12.40-53.22 ng/dL (median 19.95 ng/dL). The mean value of T1 relaxation time were 443.39 ± 113.35 ms. There is a significant correlation between serum levels of ST2 with diffuse myocardial fibrosis (Spearman correlation r = -0.547, p <0:01). Multivariate analysis showed the relationship between serum levels of ST2 and T1 relaxation time is not influenced by confounding factors (r = -0.44, p = 0.033). Conclusion: ST2 serum levels correlates with diffuse myocardial fibrosis on disglycemic population.;Background: disglycemia is a state of glucose intolerance include increased blood sugar levels associated with risk of cardiovascular disease. Over time, eventually diabetes will cause damage to the target organ, especially the cardiovascular system, which include coronary heart disease, diabetic cardiomyopathy, diabetes, cerebrovascular disease, and peripheral arterial disease. Diabetes also increases the risk of heart failure. The clinical appearance of the disease is wide ranging from asymptomatic to symptomatic heart failure. Gold standard examination to detect the occurrence of early myocardial fibrosis is histopathological examination of myocardial tissue via biopsy. However, these tests are very invasive and uncomfortable for the subject. Examination which later evolved is imaging using cardiac magnetic resonance imaging (CMRI). However, these tests are quite expensive, and not available at all health facilities. Meanwhile, ST2 is a cardiac enzyme marker that describes the degree of fibrosis process in the myocardium, especially in the state of heart failure. Examination using enzyme markers can be a cheaper alternative, widely accessible and readily available. Aim: Knowing the relationship between serum levels of ST2 with myocardial interstitial fibrosis in disglycemic patients. Methods: Disglycemic patients who passed from the exclusion criteria (cardiovascular comorbid), will undergo a serum ST2 levels and T1 relaxation time using cardiac MRI. Then we analyzed the relationship between serum levels of ST2 and T1 relaxation time. Results: A total of 34 patients were included in this study. The range values of serum ST2 levels were between 12.40-53.22 ng/dL (median 19.95 ng/dL). The mean value of T1 relaxation time were 443.39 ± 113.35 ms. There is a significant correlation between serum levels of ST2 with diffuse myocardial fibrosis (Spearman correlation r = -0.547, p <0:01). Multivariate analysis showed the relationship between serum levels of ST2 and T1 relaxation time is not influenced by confounding factors (r = -0.44, p = 0.033). Conclusion: ST2 serum levels correlates with diffuse myocardial fibrosis on disglycemic population."

"Latar belakang. Dislipidemia merupakan salah satu faktor resiko berkembangnya gagal jantung dan telah menjadi masalah kesehatan diseluruh dunia. Penelitian mengenai hubungan dislipidemia dan penyakit jantung belum banyak dilakukan di Indonesia.Tujuan. Mengetahui karakteristik pasien gagal jantung akut dan mengidentifikasi hubungan antara riwayat dislipidemia dengan mortalitas pasien gagal jantung akut selama perawatan.Metode. Penelitian dilakukan dengan desain potong lintang serta menggunakan 268 data sekunder dari studi Acute Decompensated Heart Failure Registry (ADHERE) di lima rumah sakit di Indonesia pada bulan Desember 2005 - 2006.Hasil. Pasien gagal jantung akut dalam penelitian ini dibagi kedalam dua kelompok. Kelompok pertama merupakan pasien dengan dislipidemia (88,8% dan kelompok kedua meupakan pasien tanpa dislipidemia (12,2%). Angka mortalitas pada kelompok pertama mencapai 3,0% dan pada kelompok kedua 0%. Melalui analisis bivariat tidak didapatkan hubungan bermakna antada riwayat dislipidemia dengan mortaitas pasien gagal jantung akut (p=0,603; OR: 0,828; CI: 0,101-6,759).Kesimpulan. Tidak terdapat hubungan bermakna antara riwayat dislipidemia dengan angka mortalitas gagal jantung akut selama perawatan di lima rumah sakit di Indonesia pada bulan Desember 2005 - 2006.

---

Background. Dyslipidemia can promote the development of heart failure and has become one of global health problem. The study about associatin between dyslipidemia and in-hospital mortality of acute heart failure has never been done before in Indonesia.Objective. To define the characteristic of patient and to identify the association between dyslipidemia and in-hospital mortality of acute heart failure.Method. The design of this study was cross sectional with onsecutive sampling. This study used 976 acute heart failure patients from Acute Decompensated Heart Failure Registry (ADHERE) of 5 hospital in Indonesia from December 2005-2006.Result. Patiens with acute heart failure in this study were categorized in two groups. The first group was patients with dyslipidemia (88,8%) and the second was group wihout dyslipidemia (12,2%). The mortality rate of the first group was 3,0% and from the second was 0%. The bivariat analysis showed that there is no association between dyslipidemia and in-mortality of AHF patients (p=0,603; OR: 0,828; CI: 0,101-6,759).Conclusion. There is no significant association between Dyslipidemia and Inhospital Mortality of Acute Heart Failure in Five Hospital in Indonesia on December 2005 -2006."

"Latar Belakang: Penyakit jantung merupakan penyebab kematian nomor satu dari kelompok Penyakit Tidak Menular (PTM) dan berdasarkan studi epidemiologi di Asia Tenggara, prevalensi gagal jantung di Asia Tenggara memiliki presentase yang lebih tinggi dibandingkan dengan negara lainnya. Gagal Jantung Dekompensasi Akut (GJDA) menjadi indikasi utama terjadinya admisi pada pasien dengan gagal jantung, khususnya gagal jantung dengan fraksi ejeksi rendah. Adanya kondisi hiponatremia dan hipokloremia pada pasien fraksi ejeksi rendah diharapkan dapat meningkatkan kewaspadaan bagi klinisi sebagai prediktor admisi akibat GJDA. Metode : Studi kohort retrospektif dengan menelusuri rekam medis pasien GJDA pada populasi fraksi ejeksi rendah berusia>18 tahun yang dirawat inap di RSUPN Cipto Mangunkusumo sejak tahun 2020 sampai dengan tahun 2023, dan menelusuri data elektrolit 90 hari sebelum admisi pasien dengan diagnosis GJDA pada pasien dengan fraksi ejeksi rendah. Dilakukan analisis bivariat dan juga multivariat prediktor admisi dengan diagnosis GJDA pada pasien dengan fraksi ejeksi rendah.Hasil : Dari total 265 subjek penelitian yang diletiti, analisis bivariat yang menunjukkan hiponatremia dan hipokloremia dapat menjadi prediktor admisi akibat GJDA pada pasien dengan fraksi ejeksi rendah, dengan analisis multivariat menunjukkan keduanya tetap merupakan prediktor yang baik secara statistik terkait admisi akibat GJDA pada pasien dengan fraksi ejeksi rendah dengan RR hiponatremia 1,729 (IK95% 1,367-2,179) dengan nilai P<0,001 dan OR hipokloremia 1,181 (IK95% 1,064-1,311) dengan nilai P 0,002.Kesimpulan : Hipontaremia ataupun hipokloremia pada pasien gagal jantung dengan fraksi ejeksi rendah dapat menjadi prediktor admisi akibat GJDA.

---

Background : Cardiovascular disease remains the foremost cause of mortality within the spectrum of Non-Communicable Diseases (NCDs). Epidemiological studies within Southeast Asia have illuminated a notably elevated prevalence of heart failure compared to other global regions. Acute Decompensated Heart Failure (ADHF) serves as a primary catalyst for hospital admissions, particularly among patients exhibiting diminished left ventricular ejection fraction. The identification of hyponatremia and hypochloremia in individuals with reduced ejection fraction holds promise in enhancing clinicians' vigilance as predictive markers for ADHF admissions.

Methodology : This retrospective cohort study delved into the medical records of individuals with ADHF within the low left ventricular ejection fraction cohort, aged >18 years, admitted to Dr. Cipto Mangunkusumo National Central General Hospital from 2020 to 2023. Electrolyte profiles from the 90-day period preceding ADHF diagnosis among patients with reduced ejection fraction were scrutinized. Both bivariate and multivariate analyses were conducted to delineate predictors of ADHF admissions in this subgroup.

Results : Among the 265 subjects scrutinized, bivariate analysis revealed that both hyponatremia and hypochloremia could function as robust predictors for ADHF admissions in patients displaying diminished ejection fraction. Multivariate analysis solidified their statistical significance as predictors of ADHF admissions in individuals with reduced ejection fraction. Hyponatremia exhibited an relative risk (RR) of 1.729 (95% CI 1.367-2.179) with a P-value of <0.001, while hypochloremia demonstrated an RR of 1.181 (95% CI 1.064-1.311) with a P-value of 0.002.

Conclusion : The presence of hyponatremia and hypochloremia in patients with heart failure and reduced left ventricular ejection fraction stands as a clinically significant predictive factor for ADHF admissions."

"Penyakit kardiovaskular merupakan salah satu penyebab utama kematian di Indonesia. Low Density Lipoprotein (LDL) adalah salah satu profil lemak yang memengaruhi kejadian penyakit kardiovaskular. Penelitian ini bertujuan untuk mengetahui efek buah Garcinia atroviridis sebagai alternatif terapi untuk menurunkan kadar LDL. Penelitian ini merupakan studi eksperimental, perlakuan terhadap hewan coba tikus, dibagi dalam kelompok propylthiouracil (PTU)+diet tinggi lemak, kelompok PTU, dan pemberian 3 kelompok ekstrak. Induksi dengan asupan tinggi lemak (0,375 ml gajih ayam dan 1,5 ml kuning telur puyuh) dan PTU pada kelompok PTU+diet tinggi lemak dan 3 kelompok ekstrak. Pengambilan sampel darah pada tikus PTU dan PTU+diet tinggi lemak setelah 21 hari, dan 42 hari pada kelompok ekstrak. Data dianalisis menggunakan tes parametrik one way ANOVA dan uji T tidak berpasangan. Didapatkan rata-rata LDL tiap perlakuan: (1) PTU (24,8), (2) PTU+diet tinggi lemak (52,4), (3) dosis 10 mg (22,8), (4) dosis 20 mg (25,4), (5) dosis 30 mg (36,25). Pada uji T menunjukkan kenaikan LDL yang signifikan pasca induksi, pada uji ANOVA menunjukkan penurunan LDL pasca pemberian ekstrak buah Garcinia atroviridis yang berbeda bermakna. Analisis Post Hoc menunjukkan penurunan LDL paling signifikan pada dosis 10 mg. Disimpulkan bahwa pemberian ekstrak buah Garcinia atroviridis pada tikus strain Wistar secara signifikan menurukan kadar LDL.

---

Cardiovascular disease is one of the leading cause of death in Indonesia. Low Density Lipoprotein (LDL) is one of lipid profile that has effect on cardiovascular disease. This research is aimed to discover the effect of Garcinia atroviridis fruit extract to lower LDL level. This is an experimental study, intervention was given differently to laboratory rats: propylthiouracil (PTU)+high lipid diet, PTU, and 3 extract groups. Induction is conducted with high lipid diet (0,375 ml chicken fat and 1,5 ml quail egg yolk) and PTU, in PTU with high lipid diet and 3 extract groups. Rats blood was extracted, PTU and PTU+high lipid diet after 21 days, and 42 days for extract group.

Data was analysed using one way ANOVA parametric test and independent T test. Mean LDL value of each treatment: (1) PTU (24,8), (2) PTU+high lipid diet (52,4), (3) 10 mg (22,8), (4) 20 mg (25,4), (5) 30 mg (36,25). T test showed significant result in increasing LDL level after induction and ANOVA test showed significant result in lowering LDL level after given Garcinia atroviridis fruit extract. Post Hoc analysis shows the most significant result comes from 10 mg dose. In conclussion, Garcinia atroviridis fruit extract significantly lowers blood LDL of Wistar strain rats."

"Penyakit kardiovaskular merupakan penyebab kematian nomor satu di dunia dengan angka kejadian yang terus bertambah. Salah satu faktor resiko dari penyakit ini adalah hipertrigliserida. Penelitian ini merupakan studi eksperimental yang ditujukan untuk mengetahui metode induksi peningkatan kadar trigliserida, dan efektifitas ekstrak buah Garcinia atroviridis sebagai antitrigliserida. Penelitian terbagi menjadi 2, pertama untuk mencari metode induksi, untuk membuktikan efektifitas ekstrak buah Garcinia atroviridis. Penelitian pertama terdiri dari kelompok tinggi lemak diberikan diet tinggi lemak (0,375ml gajih ayam, 1,5ml kuning telur puyuh, dan 1ml PTU) dan kelompok tanpa lemak diberikan diet standar dan PTU. Penelitian kedua terdiri dari kelompok uji diberikan diet tinggi lemak dengan jumlah yang sama ditambah dengan ekstrak buah Garcinia atroviridis dalam 3 dosis (10mg, 20mg, 30mg). Setiap kelompok tersebut kemudian dilakukan pemeriksaan kadar trigliserida darah. Hasilnya diuji dengan tes parametrik t-test untuk menguji metode induksi, dan one way ANOVA untuk menguji efektifitas ekstrak. Terdapat perbedaan tidak signifikan (p=0,255). Pada kelompok ekstrak didapatkan perbedaan yang signifikan pada kelompok uji 1a, dan 1c (p=0,006). Maka dapat disimpulkan bahwa terdapat efek yang signifikan dari ekstrak buah Garcinia atroviridis untuk menurunkan kadar trigliserida berdasarkan dosis pada darah tikus strain Wistar yang diberi asupan lemak berlebih.

---

Cardiovascular diseases, the world?s number one cause of death has certainly keep increasing. One of the risk factor is hypertriglyceride. This study is an experimental based study which was conducted to learn induction method to increase triglyceride level, and the effect of extract Garcinia atroviridis fruit extract as antitriglyceride.

This study was separated into 2, first to look for induction method, second to prove the effect of Garcinia atroviridis fruit extract. The first study consists of high-fat group that was given high fat diet (0,375ml fatty portion of chicken meat; 1,5ml quail's egg yolk; and 1ml PTU) and non-fat group, that was given standard diet and 1ml PTU. The second study consists of group treatments, which were given high fat diet and extract of Garcinia atroviridis fruit in 3 doses (10mg, 20mg, 30mg). Each group then examined for their triglyceride level.

The results were analyzed using t-test for induction method and one-way ANOVA test for the effect of extract There are no significance different between groups without extract (p=0,255). In groups with extract, there?s a significance difference between groups (p=0,006). Therefore it concluded that there are significance effect of Garcinia atroviridis fruit extract in reducing triglyceride level in Wistar strain rats blood."